63 results
Page 3 of 4
8-K
EX-99.2
ixfsf kwf4pikah
4 Aug 22
Day One Reports Second Quarter 2022 Financial Results and Corporate Progress
4:53pm
8-K
EX-99.1
dml 4liq9
24 Jun 22
Submission of Matters to a Vote of Security Holders
4:06pm
8-K
EX-1.1
gw3m7 sizlhbacnz
16 Jun 22
Day One Announces Pricing of Upsized Public Offering of Common Stock
7:33am
424B5
vivdz2wylf
16 Jun 22
Prospectus supplement for primary offering
7:30am
424B5
nehg2kutso0o by2p
14 Jun 22
Prospectus supplement for primary offering
7:39am
8-K
EX-99.2
8xj8l
13 Jun 22
Day One Announces Positive Initial Data from Pivotal FIREFLY-1 Trial of Tovorafenib (DAY101) in Relapsed Pediatric Low-Grade Glioma
6:24am
8-K
EX-99.1
vmax rxyjxbewt34l
13 Jun 22
Day One Announces Positive Initial Data from Pivotal FIREFLY-1 Trial of Tovorafenib (DAY101) in Relapsed Pediatric Low-Grade Glioma
6:24am
S-3
EX-1.2
gkg3 aq9ykmf
1 Jun 22
Shelf registration
4:06pm
S-3
sgooccow5jd
1 Jun 22
Shelf registration
4:06pm
8-K
EX-99.2
lw4gx0
12 May 22
Day One Reports First Quarter 2022 Financial Results and Provides Business Update
4:33pm
DEF 14A
5kcgnlk13 lapm8yj
28 Apr 22
Definitive proxy
4:44pm
8-K
EX-99.1
lp578
13 Apr 22
Targeted Therapies for People of All Ages April 2022
8:01am
10-K
j85txbktwv9fh8j4o0
7 Mar 22
Annual report
7:36am
10-Q
35tfy78
10 Aug 21
Quarterly report
5:26pm
424B4
qt3 9zgu9w
27 May 21
Prospectus supplement with pricing info
4:18pm
S-1/A
lg0se4sz1dtgz e6x7j
24 May 21
IPO registration (amended)
6:16am